The sequence analysis of TPO genetic materials in the cell lines confirms that the ovarian cancer cells lines as well as leukemic cells expressed the three TPO-1 (full length TPO), TPO-2 (12 bp deletion), and TPO-3 (116 pb deletion) variants. The gene discussed is SERINC5; the disease is ovarian carcinoma.